It has also been reported that the knockdown of PRKCZ leads to more rapid losses of DNA mismatch repair enzyme (MSH2) proteins, resulting in significant reductions in DNA mismatch repair (MMR) and increased resistance to thiopurines for ALL [33]. The gene discussed is PRKCZ; the disease is acute lymphoblastic leukemia.